| Product Code: ETC13172549 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Short Bowel Syndrome Drugs Market was valued at USD 0.64 Billion in 2024 and is expected to reach USD 1 Billion by 2031, growing at a compound annual growth rate of 9.30% during the forecast period (2025-2031).
The Global Short Bowel Syndrome Drugs Market is experiencing steady growth due to the increasing prevalence of short bowel syndrome as a result of surgeries or other medical conditions that necessitate the removal of a significant portion of the small intestine. The market is primarily driven by advancements in drug development, such as the introduction of novel therapies and biologic agents, aimed at improving nutrient absorption and reducing dependency on parenteral nutrition. Key players in the market are focusing on strategic collaborations, acquisitions, and product launches to expand their market presence. North America currently dominates the market, followed by Europe, but the Asia-Pacific region is anticipated to witness significant growth in the coming years. Overall, the Global Short Bowel Syndrome Drugs Market is poised for continued expansion as the understanding of the disease and its treatment options evolves.
The Global Short Bowel Syndrome Drugs Market is experiencing growth due to increasing awareness about the condition, rising prevalence of gastrointestinal disorders, and advancements in drug development. Key trends include the development of novel therapies such as GLP-2 analogs and stem cell therapy, as well as the focus on improving patient outcomes and quality of life. Opportunities in the market lie in expanding research and development activities for new drug candidates, increasing partnerships and collaborations among pharmaceutical companies, and exploring emerging markets to address unmet medical needs. Moreover, the emphasis on personalized medicine and targeted therapies is expected to drive innovation and market growth in the coming years.
The Global Short Bowel Syndrome Drugs Market faces several challenges, including limited awareness among healthcare professionals and patients about the condition and available treatment options. Additionally, the high cost of treatment and lack of insurance coverage for some medications pose barriers to access for patients. Regulatory hurdles and the lengthy and expensive drug development process also hinder the growth of the market. Moreover, the relatively small patient population with short bowel syndrome makes it less attractive for pharmaceutical companies to invest in research and development efforts, leading to a limited pipeline of new drugs. Overall, addressing these challenges will be crucial in improving patient outcomes and driving growth in the Global Short Bowel Syndrome Drugs Market.
The Global Short Bowel Syndrome (SBS) Drugs Market is primarily driven by the increasing prevalence of SBS, which is often a result of surgeries or medical conditions leading to a shortened small intestine. The rising awareness about SBS among healthcare professionals and patients, coupled with the growing research and development activities in the field of gastrointestinal disorders, are also driving market growth. Additionally, advancements in drug delivery technologies, such as oral rehydration solutions and parenteral nutrition, are further contributing to the expansion of the SBS drugs market. Furthermore, the increasing healthcare expenditure, improving healthcare infrastructure, and favorable government initiatives to support rare disease treatments are expected to fuel the demand for SBS drugs in the global market.
Government policies related to the Global Short Bowel Syndrome Drugs Market primarily focus on ensuring patient access to innovative treatments, promoting research and development in the field, and regulating the approval and marketing of these drugs. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in evaluating the safety and efficacy of short bowel syndrome drugs before they can be marketed. Additionally, government initiatives aim to incentivize pharmaceutical companies to invest in developing new therapies for this rare condition through grants, tax incentives, and expedited review processes. Overall, the government policies aim to create a supportive environment for the growth of the Global Short Bowel Syndrome Drugs Market while ensuring patient safety and access to effective treatments.
The Global Short Bowel Syndrome Drugs Market is poised for significant growth in the coming years due to the increasing prevalence of short bowel syndrome, advancements in drug development, and rising healthcare expenditure worldwide. The market is expected to witness a surge in research and development activities, leading to the introduction of innovative therapies and treatment options for patients suffering from this rare condition. Additionally, the growing awareness about the disease among healthcare professionals and patients, coupled with favorable reimbursement policies, is likely to drive market expansion. With a focus on improving the quality of life for individuals with short bowel syndrome, pharmaceutical companies are anticipated to invest in novel drug formulations and personalized medicine approaches, shaping a promising future for the global market.
In the Global Short Bowel Syndrome Drugs Market, North America holds the largest share due to the high prevalence of short bowel syndrome in the region, well-established healthcare infrastructure, and presence of key market players. Europe follows closely behind, driven by increasing awareness about the condition and the availability of advanced treatment options. Asia Pacific is expected to witness significant growth with rising healthcare expenditure, improving healthcare infrastructure, and increasing prevalence of short bowel syndrome. The Middle East and Africa region is projected to show steady growth as healthcare systems continue to develop. Latin America is also anticipated to experience growth, supported by improving access to healthcare services and increasing investments in healthcare infrastructure. Overall, all regions are expected to contribute to the growth of the global short bowel syndrome drugs market through various factors specific to each region.
Global Short Bowel Syndrome Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Short Bowel Syndrome Drugs Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Global Short Bowel Syndrome Drugs Market - Industry Life Cycle |
3.4 Global Short Bowel Syndrome Drugs Market - Porter's Five Forces |
3.5 Global Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Global Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Short Bowel Syndrome Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Global Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Short Bowel Syndrome Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Short Bowel Syndrome Drugs Market Trends |
6 Global Short Bowel Syndrome Drugs Market, 2021 - 2031 |
6.1 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Glucagon-like Peptide, 2021 - 2031 |
6.1.3 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Anti-Diarrheal, 2021 - 2031 |
6.1.4 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Histamine Blockers, 2021 - 2031 |
6.1.5 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Proton Pump Inhibitors, 2021 - 2031 |
6.1.6 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Growth Hormone, 2021 - 2031 |
6.1.7 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.4 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.5 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.4.4 Global Short Bowel Syndrome Drugs Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Short Bowel Syndrome Drugs Market, Overview & Analysis |
7.1 North America Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
7.2 North America Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 North America Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Overview & Analysis |
8.1 Latin America (LATAM) Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.4 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.6 Latin America (LATAM) Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Short Bowel Syndrome Drugs Market, Overview & Analysis |
9.1 Asia Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.4 Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.6 Asia Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Short Bowel Syndrome Drugs Market, Overview & Analysis |
10.1 Africa Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.4 Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.6 Africa Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Short Bowel Syndrome Drugs Market, Overview & Analysis |
11.1 Europe Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.4 Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.6 Europe Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Short Bowel Syndrome Drugs Market, Overview & Analysis |
12.1 Middle East Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Short Bowel Syndrome Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Short Bowel Syndrome Drugs Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Short Bowel Syndrome Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.4 Middle East Short Bowel Syndrome Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Short Bowel Syndrome Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.6 Middle East Short Bowel Syndrome Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Short Bowel Syndrome Drugs Market Key Performance Indicators |
14 Global Short Bowel Syndrome Drugs Market - Export/Import By Countries Assessment |
15 Global Short Bowel Syndrome Drugs Market - Opportunity Assessment |
15.1 Global Short Bowel Syndrome Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Short Bowel Syndrome Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.3 Global Short Bowel Syndrome Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Short Bowel Syndrome Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.5 Global Short Bowel Syndrome Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Short Bowel Syndrome Drugs Market - Competitive Landscape |
16.1 Global Short Bowel Syndrome Drugs Market Revenue Share, By Companies, 2024 |
16.2 Global Short Bowel Syndrome Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |